These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12708957)

  • 21. [Alprostan for management of critical lower limb ischemia].
    Pokrovskiĭ AV; Dan VN; Chupin AV; Kalinin AA
    Angiol Sosud Khir; 2005; 11(1):7-10. PubMed ID: 16034317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute branch retinal arterial embolism successfully treated with intravenous prostaglandin E1--case reports.
    Steigerwalt RD; Pescosolido N; Corsi M; Cesarone MR; Belcaro GV
    Angiology; 2003; 54(4):491-3. PubMed ID: 12934771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
    Neumann FJ; Diehm C; Müller-Bühl U; Weiss T; Zimmermann R; Tillmanns H; Kübler W
    Vasa Suppl; 1989; 27():40-1. PubMed ID: 2623539
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction.
    Lewis R
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S86-90. PubMed ID: 11035393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PGE(1) short term therapy in critical lower limb ischemia.
    Bandiera G; Forletta M; Di Paola FM; Cirielli C
    Int Angiol; 2003 Mar; 22(1):58-63. PubMed ID: 12771858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration of prostaglandin E1 in the treatment of patients with chronic lower limbs critical ischemia with concomitant ischemic heat disease].
    Krotovskiĭ GS; Zudin AM; Kotov AE; Uchkin IG; Zasorina MA; Mosesov AG
    Khirurgiia (Mosk); 2004; (3):31-4. PubMed ID: 15097985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.
    Creutzig A; Lehmacher W; Elze M
    Vasa; 2004 Aug; 33(3):137-44. PubMed ID: 15461065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
    Dé P; Hepp W
    Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of prostaglandin E1 in cases of occlusive arterial disease.
    Mishima Y
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():547-8. PubMed ID: 2936166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries].
    Hubl S; Wesolowski J
    Pol Tyg Lek; 1973 Jul; 28(30):1150-1. PubMed ID: 4732712
    [No Abstract]   [Full Text] [Related]  

  • 34. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 35. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease.
    Schrör K; Hohlfeld T
    Vasa; 2004 Aug; 33(3):119-24. PubMed ID: 15461062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostaglandin in the treatment of impotence].
    Tammela T
    Duodecim; 1998; 114(4):371-5. PubMed ID: 11466950
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E1 from the tip of an intraaortic balloon catheter for lower limb ischemia.
    Nakano T; Tominaga R; Shiraishi K; Yasui H
    Ann Thorac Surg; 1998 Apr; 65(4):1158-60. PubMed ID: 9564956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
    Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostaglandin E1 in chronic arterial disease: a multicenter study.
    Trübestein G; Diehm C; Gruss JD; Horsch S
    Prog Clin Biol Res; 1987; 242():445-51. PubMed ID: 3313418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.